BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹40 Cr | ₹45 Cr | ₹41 Cr | ₹15 Cr | ₹9.56 Cr |
What is the latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹40 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹9.56 Cr |
How is Sundry Debtors of BAFNA PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | -11.50 | |
| Mar2024 | ₹45 Cr | 10.32 | |
| Mar2023 | ₹41 Cr | 178.41 | |
| Mar2022 | ₹15 Cr | 54.60 | |
| Mar2021 | ₹9.56 Cr | - | |
Compare Sundry Debtors of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹288.9 Cr | -9.4% | -25.9% | 35.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -9.4% |
-25.9% |
35.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses